Author

G. Ahlen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Cell Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:differential expression· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Assay:flow cytometry· 1

Frequent Co-Authors

L. Frelin· 3 shared H.-G. Ljunggren· 2 shared J. Klingström· 2 shared J. T. Sandberg· 2 shared K. Blom· 2 shared K. T. Maleki· 2 shared M. Garcia· 2 shared M. Sällberg· 2 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

L. Frelin

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Phosphatidylinositol 4-kinase III alpha governs cytoskeletal organization for invasiveness of liver cancer cells

C. S. Tran, J. Kersten, M. Breinig, J. Yan, T. Poth, O. Colasanti, T. Riedl, S. Faure-Dupuy, S. Diehl, L. Verhoye, T.-F. Li, M. Lingemann, P. Schult, G. Ahlen, L. Frelin, , V. Lohmann

This study identifies PI4KIII's role in promoting liver cancer invasiveness through cytoskeletal reorganization via PIK3C2γ and Akt2/paxillin-cofilin signaling.

bioRxiv · May 22, 2023Cell Biology

Longitudinal characterization of humoral and cellular immunity in hospitalized COVID-19 patients reveal immune persistence up to 9 months after infection

J. T. Sandberg, R. Varnaite, W. Christ, P. Chen, J. R. Muvva, K. T. Maleki, M. Garcia, M. Dzidic, E. Folkesson, M. Skagerberg, G. Ahlen, L. Frelin, M. Sällberg, The Karolinska COVID-19 Study Group, L. I. Eriksson, , S. Gredmark-Russ

This study tracks immune responses in hospitalized COVID-19 patients up to 9 months post-infection, showing persistent neutralizing antibodies and memory B and T cells.

bioRxiv · Mar 17, 2021 · PreprintImmunology

Implications of central carbon metabolism in SARS-CoV-2 replication and disease severity

S. Krishnan, H. Nordqvist, A. T. Ambikan, S. Gupta, M. Sperk, S. Svensson-Akusjarvi, F. Mikaeloff, R. Benfeitas, E. Saccon, S. M. Ponnan, J. E. Rodriguez, N. Nikouyan, A. Odeh, G. Ahlen, M. Asghar, , U. Neogi

This study investigates how SARS-CoV-2 affects central carbon metabolism in host cells and links metabolic changes to disease severity.

bioRxiv · Feb 24, 2021Microbiology

Expansion of SARS-CoV-2-specific Antibody-secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients

R. Varnaite, M. Garcia, H. Glans, K. T. Maleki, J. T. Sandberg, J. Tynell, W. Christ, N. Lagerqvist, H. Asgeirsson, H.-G. Ljunggren, G. Ahlen, L. Frelin, M. Sällberg, K. Blom, J. Klingström, S. Gredmark-Russ

This study examines B cell and antibody responses in hospitalized COVID-19 patients, finding expanded SARS-CoV-2-specific antibody-secreting cells and neutralizing antibodies.

bioRxiv · May 28, 2020Immunology